Document:

Amended Summary of Management Incentive Plan

 Exhibit 10.23 
 CATALENT PHARMA SOLUTIONS, INC. 
 AMENDED SUMMARY OF MANAGEMENT INCENTIVE PLAN 
 This Amended Summary of Management Incentive Plan replaces, in its entirety, the Summary of Management Incentive Plan set forth in Exhibit 10.24 to
Catalent Pharma Solutions, Inc.’s Amendment No. 1 to the Registration Statement on Form S-4/A filed on March 3, 2008. 
 Catalent Pharma
Solutions, Inc. (the “Company”) has a management incentive plan (the “Plan”) for its eligible employees, which is not set forth in a written agreement. 
 The primary purpose of the Plan is to focus management on key measures that drive financial performance and provide competitive bonus opportunities tied
to the achievement of the Company’s financial and strategic growth objectives. 
 Under the MIP, the Compensation Committee of the board
of directors of the Company (the “Administrator”), or such other authorized officers of the Company that are delegated authority under the Plan by the Administrator, designates and determines which employees are eligible to participate in
the MIP. Eligibility is based on employees who are in positions to make significant contributions to the overall growth, and/or profitability of the Company or one of its subsidiaries or business segments. All named executive officers of the Company
are eligible to participate in the MIP. An eligible employee who voluntarily terminates employment prior to the payment date will forfeit any bonus award payable under the Plan. 
 A target annual bonus expressed as a percentage of base salary is established by the Administrator for each eligible employee. The MIP award, which is a
cash bonus, is tied to the financial results of the Company (the Business Performance Factor) and a combination of individual financial and/or strategic goals appropriate for each position (the Individual Performance Factor). The actual MIP awards
are the product of each employee’s Individual Performance Factor. 
 Financial performance is measured at the Company, business unit or
site level with the weighting of each level dependent upon the position. With respect to the Company’s named executive officers, financial performance is measured 100% at the company-wide level. Financial performance relative to specified
financial performance target(s) set by the Administrator determines the aggregate funding level and the Business Performance Factor are for the MIP. If the financial performance target(s) set by the Administrator are met, the aggregate bonus pool
amount and the Business Performance Factor will be set at the target amount in the annual operating budget, subject to the Administrator’s discretion. If financial performance exceeds target, the bonus pool amount and the Business Performance
Factor are increased above 100% of target based on a pre-established scale. If financial performance does not meet target, the bonus pool amount is decreased from the target amount based on the pre-established scale. The Administrator has the
discretion to adjust the MIP aggregate bonus pool amount determined by reference to the pre-established scale upwards or downwards, to address special situations. EBITDA, which may be adjusted by the Administrator to address special situations, is
currently the sole Business Performance Factor measure under the Plan.Security Agreement Supplement, dated as of July 1, 2008

 Exhibit 10.26 
 SECURITY AGREEMENT SUPPLEMENT 
 SUPPLEMENT NO. 1 (this “Supplement”), dated as of
July 1, 2008, to the Security Agreement dated as of April 10, 2007 among CATALENT PHARMA SOLUTIONS, INC. (f/k/a CARDINAL HEALTH 409, INC. (as successor by merger with PTS ACQUISITION CORP.)), PTS INTERMEDIATE HOLDINGS LLC, the Subsidiaries
of Holdings from time to time party thereto and MORGAN STANLEY SENIOR FUNDING, INC., as Collateral Agent for the Secured Parties. 
 A.
Reference is made to the Credit Agreement dated as of April 10, 2007 (as amended, supplemented or otherwise modified from time to time, the “Credit Agreement”), among the Borrower, Holdings, Morgan Stanley Senior Funding, Inc.,
as Administrative Agent, Collateral Agent and Swing Line Lender, Bank of America, N.A., as L/C Issuer and each Lender from time to time party thereto. 
 B. Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the Credit Agreement and the Security Agreement referred to therein. 
 C. The Grantors have entered into the Security Agreement in order to induce the Lenders to make Loans and the L/C Issuers to issue Letters of Credit.
Section 6.14 of the Security Agreement provides that additional Restricted Subsidiaries may become Grantors under the Security Agreement by execution and delivery of an instrument in the form of this Supplement. Each undersigned Restricted
Subsidiary (the “New Subsidiaries”) is executing this Supplement in accordance with the requirements of the Credit Agreement to become a Grantor under the Security Agreement in order to induce the Lenders to make Loans and the L/C
Issuers to issue Letters of Credit from time to time under the terms of the Credit Agreement. 
 Accordingly, the Collateral Agent and each
New Subsidiary agree as follows: 
 SECTION 1. In accordance with Section 6.14 of the Security Agreement, each New Subsidiary by its
signature below becomes a Grantor under the Security Agreement with the same force and effect as if originally named therein as a Grantor and each New Subsidiary hereby (a) agrees to all the terms and provisions of the Security Agreement
applicable to it as a Grantor thereunder and (b) represents and warrants that the representations and warranties made by it as a Grantor thereunder are true and correct on and as of the date hereof. In furtherance of the foregoing, each New
Subsidiary, as security for the payment and performance in full of the Obligations does hereby create and grant to the Collateral Agent, its successors and assigns, for the benefit of the Secured Parties, their successors and assigns, a security
interest in and lien on all of such New Subsidiary’s right, title and interest in and to the Collateral (as defined in the Security Agreement) of such New Subsidiary. Each reference to a “Grantor” in the Security Agreement
shall be deemed to include each New Subsidiary. The Security Agreement is hereby incorporated herein by reference. 
 SECTION 2. Each New
Subsidiary represents and warrants to the Collateral Agent and the other Secured Parties that this Supplement has been duly authorized, executed and delivered by it and constitutes its legal, valid and binding obligation, enforceable against it in
accordance with its terms, except as such enforceability may be limited by Debtor Relief Laws and by general principles of equity. 
 SECTION
3. This Supplement may be executed in counterparts (and by different parties hereto on different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Supplement
shall become effective when the Collateral Agent shall have received a counterpart of this Supplement that bears the signature of each New 

 I-2 
  

 Subsidiary, and the Collateral Agent has executed a counterpart hereof. Delivery of an executed signature page to this
Supplement by facsimile transmission or other electronic communication shall be as effective as delivery of a manually signed counterpart of this Supplement. 
 SECTION 4. Each New Subsidiary hereby represents and warrants that (a) set forth on Schedule I attached hereto is a true and correct schedule of the Pledged Collateral and the location of any and all Collateral
of such New Subsidiary and (b) set forth under its signature hereto is the true and correct legal name of such New Subsidiary, its jurisdiction of formation and the location of its chief executive office. 
 SECTION 5. Except as expressly supplemented hereby, the Security Agreement shall remain in full force and effect. 
 SECTION 6. THIS SUPPLEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. 
 SECTION 7. In case any one or more of the provisions contained in this Supplement should be held invalid, illegal or unenforceable in any respect, the
validity, legality and enforceability of the remaining provisions contained herein and in the Security Agreement shall not in any way be affected or impaired thereby (it being understood that the invalidity of a particular provision in a particular
jurisdiction shall not in and of itself affect the validity of such provision in any other jurisdiction). The parties hereto shall endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions
the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions. 
 SECTION 8. All
communications and notices hereunder shall be in writing and given as provided in Section 6.01 of the Security Agreement. 
 SECTION 9.
The New Subsidiary agrees to reimburse the Collateral Agent for its reasonable out-of-pocket expenses in connection with this Supplement, including the reasonable fees, other charges and disbursements of counsel for the Collateral Agent. 

[Remainder of Page Intentionally Blank] 

 I-3 
  

 IN WITNESS WHEREOF, each New Subsidiary and the Collateral Agent have duly executed this Supplement to
the Security Agreement as of the day and year first above written. 
  

			
	CATALENT US HOLDING I, LLC
		
	By:	 	/s/ Craig Collingwood
	Name:	 	Craig Collingwood
	Title:	 	Secretary
	
	Jurisdiction of Formation: Delaware
	
	 Address of Chief Executive Office:
 Catalent
US Holding I, LLC, c/o Catalent U.K.
 Swindon Encaps Limited, Frankland Road,
 Blagrove, Swindon, Wiltshire SN5 8YG,
 England

  
  
  

			
	CATALENT US HOLDING II, LLC
		
	By:	 	/s/ Craig Collingwood
	Name:	 	Craig Collingwood
	Title:	 	Secretary
	
	Jurisdiction of Formation: Delaware
	
	 Address Of Chief Executive Office:
 Catalent
US Holding II, LLC, c/o Catalent U.K.
 Swindon Encaps Limited, Frankland Road,
 Blagrove, Swindon, Wiltshire SN5 8YG,
 England

 I-4 
  

			
	 MORGAN STANLEY SENIOR FUNDING, INC.,
 as
Collateral Agent

		
	By:	 	/s/ Stephen B. King
	Name:	 	Stephen B. King
	Title:	 	Vice President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}]]